Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 794862, 10 pages
http://dx.doi.org/10.1155/2015/794862
Research Article

Hepatocyte-Specific Ablation of PP2A Catalytic Subunit α Attenuates Liver Fibrosis Progression via TGF-β1/Smad Signaling

1Department of Anatomy, Histology and Embryology, Nanjing Medical University, Nanjing, Jiangsu 210029, China
2Model Animal Research Center of Nanjing University, Nanjing, Jiangsu 210061, China

Received 1 September 2014; Revised 18 November 2014; Accepted 18 November 2014

Academic Editor: Yury Popov

Copyright © 2015 Na Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Friedman, “Evolving challenges in hepatic fibrosis,” Nature Reviews Gastroenterology & Hepatology, vol. 7, no. 8, pp. 425–436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Parola, F. Marra, and M. Pinzani, “Myofibroblast—like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 58–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Dranoff and R. G. Wells, “Portal fibroblasts: underappreciated mediators of biliary fibrosis,” Hepatology, vol. 51, no. 4, pp. 1438–1444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rosselli, J. MacNaughtan, R. Jalan, and M. Pinzani, “Beyond scoring: a modern interpretation of disease progression in chronic liver disease,” Gut, vol. 62, no. 9, pp. 1234–1241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. L. Friedman, “Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury,” The Journal of Biological Chemistry, vol. 275, no. 4, pp. 2247–2250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Iredale, “Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 539–548, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Wallace, A. D. Burt, and M. C. Wright, “Liver fibrosis,” Biochemical Journal, vol. 411, no. 1, pp. 1–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Eghbali-Fatourechi, G. C. Sieck, Y. S. Prakash, P. Maercklein, G. J. Gores, and L. A. Fitzpatrick, “Type I procollagen production and cell proliferation is mediated by transforming growth factor-β in a model of hepatic fibrosis,” Endocrinology, vol. 137, no. 5, pp. 1894–1903, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Gressner and R. Weiskirchen, “Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets,” Journal of Cellular and Molecular Medicine, vol. 10, no. 1, pp. 76–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Virshup and S. Shenolikar, “From promiscuity to precision: protein phosphatases get a makeover,” Molecular Cell, vol. 33, no. 5, pp. 537–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Virshup, “Protein phosphatase 2A: a panoply of enzymes,” Current Opinion in Cell Biology, vol. 12, no. 2, pp. 180–185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Arino, C. W. Woon, D. L. Brautigan, T. B. Miller Jr., and G. L. Johnson, “Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 12, pp. 4252–4256, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Khew-Goodall and B. A. Hemmings, “Tissue-specific expression of mRNAs encoding α- and β-catalytic subunits of protein phosphatase 2A,” FEBS Letters, vol. 238, no. 2, pp. 265–268, 1988. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Khew-Goodall, R. E. Mayer, F. Maurer, S. R. Stone, and B. A. Hemmings, “Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes,” Biochemistry, vol. 30, no. 1, pp. 89–97, 1991. View at Google Scholar
  16. I. Griswold-Prenner, C. Kamibayashi, E. M. Maruoka, M. C. Mumby, and R. Derynck, “Physical and functional interactions between type I transforming growth factor β receptors and Bα, a WD-40 repeat subunit of phosphatase 2A,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6595–6604, 1998. View at Google Scholar · View at Scopus
  17. C. Petritsch, H. Beug, A. Baimain, and M. Oft, “TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest,” Genes and Development, vol. 14, no. 24, pp. 3093–3101, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Batut, B. Schmierer, J. Cao, L. A. Raftery, C. S. Hill, and M. Howell, “Two highly related regulatory subunits of PP2A exert opposite effects on TGF-β/activin/nodal signalling,” Development, vol. 135, no. 17, pp. 2927–2937, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Chen, P. Gu, X. Jiang, H.-B. Ruan, C. Li, and X. Gao, “Protein phosphatase 2A catalytic subunit α (PP2Acα) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway,” The American Journal of Pathology, vol. 178, no. 5, pp. 2333–2343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. Wynn, “Cellular and molecular mechanisms of fibrosis,” Journal of Pathology, vol. 214, no. 2, pp. 199–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Götz, A. Probst, E. Ehler, B. Hemmings, and W. Kues, “Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 21, pp. 12370–12375, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Okamura, D. Yang, K. Yoshida, J. Teramachi, and T. Haneji, “Reduction of PP2A Cα stimulates adipogenesis by regulating the Wnt/GSK-3β/β-catenin pathway and PPARγ expression,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1843, pp. 2376–2384, 2014. View at Publisher · View at Google Scholar
  23. R. Bravo, “Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication,” Experimental Cell Research, vol. 163, no. 2, pp. 287–293, 1986. View at Publisher · View at Google Scholar · View at Scopus
  24. M. B. Bansal, K. Kovalovich, R. Gupta et al., “Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression,” Journal of Hepatology, vol. 42, no. 4, pp. 548–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Xu, C. Hellerbrand, U. A. Köhler et al., “The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis,” Laboratory Investigation, vol. 88, no. 10, pp. 1068–1078, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Şerbetçi, O. Uysal, N. Erkasap, T. Köken, C. Baydemir, and S. Erkasap, “Anti-apoptotic and antioxidant effect of leptin on CCl4-induced acute liver injury in rats,” Molecular Biology Reports, vol. 39, no. 2, pp. 1173–1180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tamura, S. Simizu, and H. Osada, “The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria,” FEBS Letters, vol. 569, no. 1–3, pp. 249–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Geerts, “History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells,” Seminars in Liver Disease, vol. 21, no. 3, pp. 311–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Safadi and S. L. Friedman, “Hepatic fibrosis—role of hepatic stellate cell activation,” MedGenMed, vol. 4, no. 3, p. 27, 2002. View at Google Scholar · View at Scopus
  30. A. Mallat and S. Lotersztajn, “Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis,” American Journal of Physiology—Cell Physiology, vol. 305, no. 8, pp. C789–C799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. U. E. Lee and S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Best Practice & Research: Clinical Gastroenterology, vol. 25, no. 2, pp. 195–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Breitkopf, P. Godoy, L. Ciuclan, M. V. Singer, and S. Dooley, “TGF-β/Smad signaling in the injured liver,” Zeitschrift fur Gastroenterologie, vol. 44, no. 1, pp. 57–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Inagaki and I. Okazaki, “Emerging insights into transforming growth factor β Smad signal in hepatic fibrogenesis,” Gut, vol. 56, no. 2, pp. 284–292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley, “Roles of TGF-beta in hepatic fibrosis,” Front Biosci, vol. 7, pp. d793–d807, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Dooley and P. Ten Dijke, “TGF-β in progression of liver disease,” Cell and Tissue Research, vol. 347, no. 1, pp. 245–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Jungert, M. Buchholz, M. Wagner, G. Adler, T. M. Gress, and V. Ellenrieder, “Smad-Sp1 complexes mediate TGFβ-induced early transcription of oncogenic Smad7 in pancreatic cancer cells,” Carcinogenesis, vol. 27, no. 12, pp. 2392–2401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Cocolakis, M. Dai, L. Drevet et al., “Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation,” Journal of Biological Chemistry, vol. 283, no. 3, pp. 1293–1307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. I. K. Sung, H. K. Joon, L. Wang, and M. E. Choi, “Protein phosphatase 2A is a negative regulator of transforming growth factor-β1-induced TAK1 activation in mesangial cells,” The Journal of Biological Chemistry, vol. 283, no. 16, pp. 10753–10763, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Kajino, H. Ren, S.-I. Iemura et al., “Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway,” The Journal of Biological Chemistry, vol. 281, no. 52, pp. 39891–39896, 2006. View at Publisher · View at Google Scholar · View at Scopus